Glenmark Pharma on the sale of its portfolio of CNS products in Poland to Neuraxpharm
Glenmark Pharma on its divestment of its CNS business in Poland including its portfolio of generics and branded generics products and the transfer of its commercial team in Poland to private equity backed Neuraxpharm, a specialty pharmaceutical company focused on the treatment of CNS disorders.
Cara Real Estate, the real estate arm of Cara Investment, on its acquisition of 7-10 Waterloo Place from real estate investment manager Barings. The Grade II listed office building in St James' was sold for GBP71m and is Cara's second London deal following the purchase of 20 Soho Square for GBP117m in 2018. This transaction drew on the deep expertise offered by the firm's real estate, construction, planning, banking and finance and corporate teams.
Early-stage tech investor Dawn Capital on its secondary purchase of shares from shareholders of Dataiku Inc.
This values Dataiku at over USD1 billion. This is one of a long line of deals that Taylor Wessing has advised Dawn Capital on having also advised Dawn Capital on its participation in the EUR 90 million funding round for European open banking platform Tink; and its participation in the £29m Series B round for natural language processing company Eigen Technologies.
First law firm appointment of an independent review process for a major retail bank
Advising Professor Griggs, the Independent Reviewer appointed by Lloyds in relation to the HBOS Redress Programme. This is a substantial investigation into over 50 former HBoS corporate customers, analysis of their claims for compensation and independent assessment of the bank's redress proposals. We are the first firm to handle an independent review process for a major retail bank on this scale. Our mandate continues, with us now advising Professor Griggs on the Quality Assurance Review by Sir Ross Cranston of the HBOS Reading Compensation Scheme itself.
